Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment | Zendy

Kaavya Jayaramayya | Zendy; Mahalaxmi Iyer | Zendy; Mohana Devi Subramaniam | Zendy; Neethu Raj | Zendy; Ahmed Abdal Dayem | Zendy; Kyung Min Lim | Zendy; SeJong Kim | Zendy; Jong Yub An | Zendy; Yoon-Joo Lee | Zendy; Yujin Choi | Zendy; Arthi Kirubhakaran | Zendy; SsangGoo Cho | Zendy; Balachandar Vellingiri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment

Author(s) -

Kaavya Jayaramayya,

Mahalaxmi Iyer,

Mohana Devi Subramaniam,

Neethu Raj,

Ahmed Abdal Dayem,

Kyung Min Lim,

SeJong Kim,

Jong Yub An,

Yoon-Joo Lee,

Yujin Choi,

Arthi Kirubhakaran,

SsangGoo Cho,

Balachandar Vellingiri

Publication year - 2020

Publication title -

bmb reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.511

H-Index - 77

eISSN - 1976-670X

pISSN - 1976-6696

DOI - 10.5483/bmbrep.2020.53.8.121

Subject(s) - mesenchymal stem cell , microvesicles , stem cell , covid-19 , microbiology and biotechnology , virology , biology , cancer research , medicine , microrna , pathology , genetics , disease , gene , infectious disease (medical specialty)

The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse treatment options to effectively treat people worldwide. Since the immune system is at the hub of the infection, it is essential to regulate the dynamic balance in order to prevent the overexaggerated immune responses that subsequently result in multiorgan damage. The use of stem cells as treatment options has gained tremend-ous momentum in the past decade. The revolutionary mea-sures in science have brought to the world mesenchymal stem cells (MSCs) and MSC-derived exosomes (MSC-Exo) as thera-peutic opportunities for various diseases. The MSCs and MSC-Exos have immunomodulatory functions; they can be used as therapy to strike a balance in the immune cells of patients with COVID-19. In this review, we discuss the basics of the cyto-kine storm in COVID-19, MSCs, and MSC-derived exosomes and the potential and stem-cell-based ongoing clinical trials for COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research